Clinical Trials

Showing 141 - 160 of 444 trials
Titlesort icon Investigator Disease(s)
A Phase IB/II Study of IPI-504 plus Everolimus in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 11-114]
Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase IB/II Study of OMP-59R5 with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
[Protocol 12-234]
O'Reilly, Eileen
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase IB/IIA Study of ABT-888 in Combination with Bendamustine with or without Rituximab in Patients with Lymphoma, Multiple Myeloma, and Solid Tumors
[Protocol 10-174]
Gerecitano, John
  • Hematology
    • Multiple Myeloma
  • Lymphoma
A Phase IB/IIA Study of Romidepsin plus Lenalidomide in Adults with Relapsed or Refractory Lymphoma and Myeloma
[Protocol 12-170]
Horwitz, Steven
  • Hematology
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Low-Risk Prostate Cancer
[Protocol 11-056]
Zelefsky, Michael
  • Prostate Cancer
    • Localized Disease
A Phase II Study Evaluating Manuka Honey to Reduce Chemoradiation-Associated Esophagitis Pain during Lung Cancer Treatment
[Protocol 12-111]
Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
  • Lung Cancer, Small Cell
    • Other
A Phase II Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094]
Wu, Abraham
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Abiraterone, Exemestane, or Both in Postmenopausal Women with ER-Positive Metastatic Breast Cancer
[Protocol 12-140]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Abiraterone, Prednisone, and Degarelix in Men with Recurrent Prostate Cancer and a Rising PSA
[Protocol 12-187]
Scher, Howard
  • Prostate Cancer
    • Rising PSA After Primary Therapy
A Phase II Study of Abraxane with or without Tigatuzumab in Patients with Metastatic Triple-Negative Breast Cancer
[Protocol 11-082]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Adjuvant Bevacizumab, Metronomic Chemotherapy, Diet, and Exercise After Preoperative Chemotherapy for Breast Cancer
[Protocol 11-063]
Dickler, Maura
  • Breast Cancer
A Phase II Study of Afatinib (BIBW 2992) in Patients with Advanced HER2-Positive Esophagogastric Cancer Refractory to Trastuzumab
[Protocol 11-166]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of AUY922 in Patients with Myelofibrosis
[Protocol 12-076]
Rampal, Raajit
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
  • Leukemia
    • Myeloproliferative Neoplasm
A Phase II Study of Axitinib in Patients with Recurrent, Progressive/Metastatic Adenoid Cystic Cancer
[Protocol 12-004]
Ho, Alan
  • Head & Neck Cancer
A Phase II Study of Bendamustine and Dexamethasone in Patients with Relapsed Amyloidosis
[Protocol 12-257]
Landau, Heather
  • Hematology
    • Hematologic Malignancies
A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma
[Protocol 10-015]
Modak, Shakeel
  • Neuroblastoma
A Phase II Study of BKM120 in Metastatic Transitional Cell Carcinoma of the Urothelium
[Protocol 11-060]
Bajorin, Dean
  • Bladder Cancer
A Phase II Study of BKM120 in Patients with Metastatic Non-Small Cell Lung Cancer
[Protocol 11-157]
Paik, Paul
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of BKM120 in Patients with Recurrent Glioblastoma and an Activated PI3K Pathway
[Protocol 12-002]
Mellinghoff, Ingo
  • Pediatric Brain Tumors
    • Brain Cancer